News

AstraZeneca Books Record Quarterly Revenue as Oncology Boosts Growth
The pharmaceutical giant said second-quarter revenue increased to $14.46 billion from $12.94 billion. Revenue in its oncology ...
AstraZeneca share price forecast after earnings
AstraZeneca share price held steady this week after the company published strong financial results on Tuesday.
Live: FTSE 100 Rises on Boost from Barclays, AstraZeneca
Jefferies analysts note that FX was a significant headwind and it wasn’t quite clear the extent to which that had been ...
FTSE 100 Live 29 July: AstraZeneca results cheer, Barclays profit beats hopes
Barclays today said half-year pre-tax profits rose 23% to £5.2 billion, boosted by a 28% improvement in the second quarter of ...
Fierce Biotech4h
AstraZeneca drops lead T-cell receptor therapy from $200M Neogene buy
AstraZeneca has dropped the lead candidate from its $200 million buyout of Neogene Therapeutics as part of a wider cell ...
Can this latest news kickstart AstraZeneca’s share price momentum?
The AstraZeneca share price has been treading water for the past few years, but first-half results add strength to rising ...
Explore more
DPA International on MSN3h
AstraZeneca reports profit jump in second quarter, confirms outlook
Profit and revenue for British-Swedish drug major AstraZeneca were up in the second quarter, the company reported on Tuesday, ...
AstraZeneca beats forecasts after record US growth
AstraZeneca’s revenues beat expectations for the second quarter, powered by record growth in its all-important US business.
Astrazeneca: Q2 Earnings Snapshot
On a per-share basis, the Cambridge, Britain-based company said it had net income of 79 cents. Earnings, adjusted for non-recurring costs, came to $1.09 per share. The results met Wall Street ...